Clinical Study to Evaluate Safety and Immunogenicity of Different Formulations of MF59-Adjuvanted Quadrivalent Subunit inactivated Cell-derived Influenze Vaccine (aQIVc) in Older Adults
| Funding period: 2021 - 2021
Completed
| Funding period: 2021 - 2021
Completed